| Symbol | Company | Weighting |
|---|---|---|
| AMGN | AMGEN CORP | 5.06% |
| VRTX | VERTEX PHARMACEUTICALS INC | 4.66% |
| ZTS | ZOETIS INC | 4.56% |
| ABBV | ABBVIE INC | 4.45% |
| ALKS | ALKERMES INC | 4.34% |
| GILD | GILEAD SCIENCES INC | 4.16% |
| JNJ | JOHNSON & JOHNSON | 4.07% |
| PFE | PFIZER INC | 4.02% |
| LLY | ELI LILLY CORP | 3.92% |
| MRK | MERCK & CO. NEW | 3.86% |
| REGN | REGENERON PHARMACEUTICALS | 3.81% |
| WST | WEST PHARMACEUTICAL SERVICES INC | 3.71% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 3.26% |
| EW | EDWARDS LIFESCIENCES CORP | 3.17% |
| CI | THE CIGNA GROUP | 3.17% |
| CVS | CVS HEALTH CORPORATION | 3.09% |
| TMO | THERMO FISHER SCIENTIFIC INC | 3.00% |
| EHC | ENCOMPASS HEALTH CORP NPV | 2.94% |
| SYK | STRYKER CORP | 2.92% |
| LH | LABCORP HOLDINGS INC | 2.86% |
| DHR | DANAHER CORP | 2.83% |
| MDT | MEDTRONIC PLC | 2.71% |
| MCK | MCKESSON CORP | 2.63% |
| ABT | ABBOTT LABORATORIES | 2.39% |
| BSX | BOSTON SCIENTIFIC | 2.22% |
| ISRG | INTUITIVE SURGICAL INC | 2.14% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.91% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.80% |
| VEEV | VEEVA SYSTEMS INC CLASS A | 1.73% |
| IDYA | IDEAYA BIOSCIENCES, INC | 1.61% |
| PODD | INSULET CORP | 1.57% |
| PHR | PHREESIA INC | 1.43% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Private Investments, LLC, Guggenheim Investments Loan Advisors, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.